Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tsunoda

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[Development for a novel cancer vaccine]Takuya Tsunoda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 15, 2021
[Gut Microbiota and Tumor Immune Microenvironment]Kiyoshi Yoshimura, Takuya Tsunoda
Life (Basel, Switzerland)|August 26, 2022
Emerging Immune-Monitoring System for Immune Checkpoint InhibitorsKazuyuki Hamada, Takuya Tsunoda, Kiyoshi Yoshimura
Human Vaccines & Immunotherapeutics|January 25, 2022
Future prospects for cancer immunotherapy - Strategies for ineffective cancersSatoshi Wada, Shinichi Kobayashi, Takuya Tsunoda
Cureus|December 27, 2024
Severe Polymyalgia Rheumatica-Like Syndrome Induced by Immune Checkpoint Inhibitor: A Case Report and Literature ReviewToshiaki Tsurui, Hirotsugu Ariizumi, Yutaro Kubota, et al.
World Journal of Clinical Oncology|April 28, 2025
Oxaliplatin-induced diffuse alveolar hemorrhage: A case reportToshiaki Tsurui, Emiko Mura, Atsushi Horiike, et al.
Cancer Research|July 23, 2003
Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptideSaori Nakahara, Takuya Tsunoda, Toshiyuki Baba, et al.
World Journal of Gastrointestinal Oncology|March 1, 2024
Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case reportToshiaki Tsurui, Yuya Hirasawa, Yutaro Kubota, et al.
Cancer Science|September 6, 2007
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapyTakako Suda, Takuya Tsunoda, Yataro Daigo, et al.
Surgery Today|January 28, 2005
Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a caseYuichi Ando, Takuya Tsunoda, Yoshifumi Beck, et al.
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 5, 2005
[Development for a novel cancer vaccine]Takuya Tsunoda
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 15, 2021
[Gut Microbiota and Tumor Immune Microenvironment]Kiyoshi Yoshimura, Takuya Tsunoda
Life (Basel, Switzerland)|August 26, 2022
Emerging Immune-Monitoring System for Immune Checkpoint InhibitorsKazuyuki Hamada, Takuya Tsunoda, Kiyoshi Yoshimura
Human Vaccines & Immunotherapeutics|January 25, 2022
Future prospects for cancer immunotherapy - Strategies for ineffective cancersSatoshi Wada, Shinichi Kobayashi, Takuya Tsunoda
Cureus|December 27, 2024
Severe Polymyalgia Rheumatica-Like Syndrome Induced by Immune Checkpoint Inhibitor: A Case Report and Literature ReviewToshiaki Tsurui, Hirotsugu Ariizumi, Yutaro Kubota, et al.
World Journal of Clinical Oncology|April 28, 2025
Oxaliplatin-induced diffuse alveolar hemorrhage: A case reportToshiaki Tsurui, Emiko Mura, Atsushi Horiike, et al.
Cancer Research|July 23, 2003
Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptideSaori Nakahara, Takuya Tsunoda, Toshiyuki Baba, et al.
World Journal of Gastrointestinal Oncology|March 1, 2024
Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case reportToshiaki Tsurui, Yuya Hirasawa, Yutaro Kubota, et al.
Cancer Science|September 6, 2007
Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapyTakako Suda, Takuya Tsunoda, Yataro Daigo, et al.
Surgery Today|January 28, 2005
Effect of imatinib (STI571) on metastatic gastrointestinal stromal tumors: report of a caseYuichi Ando, Takuya Tsunoda, Yoshifumi Beck, et al.
Pageof 13